- Home
- CTS vs DAWN Comparison
CTS vs DAWN Comparison
Compare CTS & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTS
- DAWN
- Stock Information
- Founded
- CTS 1896
- DAWN 2018
- Country
- CTS United States
- DAWN United States
- Employees
- CTS N/A
- DAWN N/A
- Industry
- CTS Electrical Products
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- CTS Technology
- DAWN Health Care
- Exchange
- CTS Nasdaq
- DAWN Nasdaq
- Market Cap
- CTS 1.6B
- DAWN 1.3B
- IPO Year
- CTS N/A
- DAWN 2021
- Fundamental
- Price
- CTS $48.19
- DAWN $12.29
- Analyst Decision
- CTS Hold
- DAWN Strong Buy
- Analyst Count
- CTS 1
- DAWN 7
- Target Price
- CTS $46.00
- DAWN $36.33
- AVG Volume (30 Days)
- CTS 127.5K
- DAWN 1.1M
- Earning Date
- CTS 02-04-2025
- DAWN 02-24-2025
- Dividend Yield
- CTS 0.34%
- DAWN N/A
- EPS Growth
- CTS N/A
- DAWN N/A
- EPS
- CTS 1.89
- DAWN N/A
- Revenue
- CTS $515,770,999.00
- DAWN $101,953,000.00
- Revenue This Year
- CTS N/A
- DAWN N/A
- Revenue Next Year
- CTS $5.85
- DAWN $34.82
- P/E Ratio
- CTS $24.94
- DAWN N/A
- Revenue Growth
- CTS N/A
- DAWN N/A
- 52 Week Low
- CTS $42.20
- DAWN $11.13
- 52 Week High
- CTS $59.68
- DAWN $18.07
- Technical
- Relative Strength Index (RSI)
- CTS 28.20
- DAWN 44.59
- Support Level
- CTS $44.00
- DAWN $11.93
- Resistance Level
- CTS $52.39
- DAWN $13.53
- Average True Range (ATR)
- CTS 1.34
- DAWN 0.56
- MACD
- CTS -0.41
- DAWN 0.03
- Stochastic Oscillator
- CTS 32.22
- DAWN 35.21
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.